Combined menin-MLL and FLT3 inhibition had synergistic antiproliferative and proapoptotic effects in models of human NPM1-mutated or MLL-rearranged AML with additional FLT3-ITD [194]. This evidence concerns the gene KMT2A and acute myeloid leukemia.